Laurentian Bank Securities
Laurentian Bank Securities is an integrated full-service investment dealer based in Montreal, Canada, established in 1991. The firm operates across six business lines, including a respected institutional fixed income division that focuses on government and corporate underwritings as well as secondary markets. Its institutional equity division specializes in research, trading, and investment banking targeted at small capitalization companies. Additionally, the retail and discount brokerage divisions serve clients through 13 offices in Québec, while the firm acts as a carrying broker, providing comprehensive back-office support to various customers. Laurentian Bank Securities also offers an Immigrant Investors program and provides a range of investment banking services, including mergers and acquisitions, public offerings, and private placements, catering to diverse industries such as agriculture, natural resources, infrastructure, transportation, and technology. The firm emphasizes expertise and innovation to deliver added value in both the institutional and retail markets.
Fronsac Real Estate Investment Trust (the Trust) is a Canada-based open-ended real estate investment trust. The Trust owns and rents commercial real estate properties. The Trust's segments include Major canadian oil and gas company, International fast-food company, International convenience store company, and Others. The Trust operates in the commercial real estate market. The Trust holds approximately 20 investment properties, which are located in the province of Quebec and the province of Ontario. The Trust's properties are occupied by tenants, including fast food chains, oil/gas companies, and convenience store chains. The Trust's properties include Les Coteaux, Rivieres-du-Loup, Saint-Jean-sur-le-Richelieu, Trois-Rivieres, Val-David, Cap-de-la-Madeleine, Louiseville, Levis, Cornwall, 1901 Raymond Blais, 2000 Leonard de Vinci, 2050 Leonard de Vinci, 2051 Nobel and 4200 Bernard-Pilon.
Troilus Gold is a Canadian based development stage resource company focused on the potential restart and mineral expansion of the former producing Troilus gold and copper mine, located within the Frotêt-Evans Greenstone Belt in Quebec.
Fronsac Real Estate Investment Trust (the Trust) is a Canada-based open-ended real estate investment trust. The Trust owns and rents commercial real estate properties. The Trust's segments include Major canadian oil and gas company, International fast-food company, International convenience store company, and Others. The Trust operates in the commercial real estate market. The Trust holds approximately 20 investment properties, which are located in the province of Quebec and the province of Ontario. The Trust's properties are occupied by tenants, including fast food chains, oil/gas companies, and convenience store chains. The Trust's properties include Les Coteaux, Rivieres-du-Loup, Saint-Jean-sur-le-Richelieu, Trois-Rivieres, Val-David, Cap-de-la-Madeleine, Louiseville, Levis, Cornwall, 1901 Raymond Blais, 2000 Leonard de Vinci, 2050 Leonard de Vinci, 2051 Nobel and 4200 Bernard-Pilon.
Eastmain Resources Inc., together with its subsidiary, Eastmain Mines Inc., engages in the acquisition and exploration of metallic mineral resource properties in Canada. Its flagship project is the Clearwater project located in the James Bay region of Québec. The company was incorporated in 1982 and is headquartered in Toronto, Canada. As of October 9, 2020, Eastmain Resources Inc. operates as a subsidiary of Fury Gold Mines Limited.
Knight Therapeutics Inc. is a Montreal-based specialty pharmaceutical company engaged in the development, acquisition, in-licensing, and distribution of pharmaceutical and consumer health products, as well as medical devices, both in Canada and internationally. The company markets several products, including Movantik for opioid-induced constipation, Neuragen for pain associated with neuropathy, and Mytesi for noninfectious diarrhea in adults with HIV or AIDS. Additionally, it has a diverse pipeline that includes therapies for conditions such as opioid addiction, chronic pain, diabetic macular edema, and various cancers. Knight Therapeutics also invests in life sciences and finances other companies within the sector. Founded in 2013, the company aims to bring innovative healthcare solutions to the market and improve patient outcomes.
Knight Therapeutics Inc. is a Montreal-based specialty pharmaceutical company engaged in the development, acquisition, in-licensing, and distribution of pharmaceutical and consumer health products, as well as medical devices, both in Canada and internationally. The company markets several products, including Movantik for opioid-induced constipation, Neuragen for pain associated with neuropathy, and Mytesi for noninfectious diarrhea in adults with HIV or AIDS. Additionally, it has a diverse pipeline that includes therapies for conditions such as opioid addiction, chronic pain, diabetic macular edema, and various cancers. Knight Therapeutics also invests in life sciences and finances other companies within the sector. Founded in 2013, the company aims to bring innovative healthcare solutions to the market and improve patient outcomes.
Integra's primary focus is on exploring and advancing its high-grade Lamaque South project in Val-d'Or, Québec.
Knight Therapeutics Inc. is a Montreal-based specialty pharmaceutical company engaged in the development, acquisition, in-licensing, and distribution of pharmaceutical and consumer health products, as well as medical devices, both in Canada and internationally. The company markets several products, including Movantik for opioid-induced constipation, Neuragen for pain associated with neuropathy, and Mytesi for noninfectious diarrhea in adults with HIV or AIDS. Additionally, it has a diverse pipeline that includes therapies for conditions such as opioid addiction, chronic pain, diabetic macular edema, and various cancers. Knight Therapeutics also invests in life sciences and finances other companies within the sector. Founded in 2013, the company aims to bring innovative healthcare solutions to the market and improve patient outcomes.
Azimut Exploration Inc. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It explores for copper, gold, zinc, silver, cobalt, tungsten, rare earth elements, uranium, chromium, nickel, and platinum group elements. As at December 22, 2020, the company holds an exploration portfolio of twenty-eight exploration properties, comprising of 11,916 claims in the James Bay and Nunavik regions. The company is headquartered in Longueuil, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.